share_log

藥明康德:於2024年第二季度2019年A股激勵計劃調整後首次授予第三個行權期授出的部分股票期權行權

WUXI APPTEC: EXERCISE OF PART OF THE SHARE OPTIONS GRANTEDUNDER THE ADJUSTED INITIAL GRANT OFTHE 2019 A SHARE INCENTIVE PLANFOR THE THIRD VESTING PERIOD DURINGTHE SECOND QUARTER OF 2024

HKEX ·  Jul 1 06:42

Summary by Moomoo AI

药明康德於2024年第二季度完成2019年A股激勵計劃第三個行權期的股票期權行權。該行權期自2023年6月27日至2024年5月25日,共有307名激勵對象參與行權,行權股票數量達1,690,933股,佔可行權總數的98.14%。行權後,公司將註銷未行權的31,509份股票期權。此次行權導致無限售條件的A股減少21,400,687股,但公司股權架構及實際控制人未發生變動。本次股權變動已於中國證券登記結算有限責任公司上海分公司完成登記。
药明康德於2024年第二季度完成2019年A股激勵計劃第三個行權期的股票期權行權。該行權期自2023年6月27日至2024年5月25日,共有307名激勵對象參與行權,行權股票數量達1,690,933股,佔可行權總數的98.14%。行權後,公司將註銷未行權的31,509份股票期權。此次行權導致無限售條件的A股減少21,400,687股,但公司股權架構及實際控制人未發生變動。本次股權變動已於中國證券登記結算有限責任公司上海分公司完成登記。
In the second quarter of 2024, WuXi AppTec completed the stock option exercise of the third tranche of its A-share incentive plan in 2019. The exercise period was from June 27, 2023 to May 25, 2024, with 307 incentive targets participating in the exercise and a total of 1,690,933 shares of the options exercised, accounting for 98.14% of the total exercisable shares. After the exercise, the company will cancel 31,509 unexercised stock options. This exercise resulted in a reduction of 21,400,687 shares of A-shares subject to unlimited sales conditions, but the company's equity structure and actual controller remained unchanged. This equity change has been registered with the Shanghai branch of China Securities Depository and Clearing Corporation Limited.
In the second quarter of 2024, WuXi AppTec completed the stock option exercise of the third tranche of its A-share incentive plan in 2019. The exercise period was from June 27, 2023 to May 25, 2024, with 307 incentive targets participating in the exercise and a total of 1,690,933 shares of the options exercised, accounting for 98.14% of the total exercisable shares. After the exercise, the company will cancel 31,509 unexercised stock options. This exercise resulted in a reduction of 21,400,687 shares of A-shares subject to unlimited sales conditions, but the company's equity structure and actual controller remained unchanged. This equity change has been registered with the Shanghai branch of China Securities Depository and Clearing Corporation Limited.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more